Short-term thalidomide incorporated into double autologous stem-cell transplantation improves outcomes in comparison with double autotransplantation for multiple myeloma.

Source:http://linkedlifedata.com/resource/pubmed/id/19720903

J. Clin. Oncol. 2009 Oct 20 27 30 5001-7

Download in:

View as

General Info

PMID
19720903